Patents by Inventor Roger Carolus Augusta Embrechts

Roger Carolus Augusta Embrechts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180133174
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: January 10, 2018
    Publication date: May 17, 2018
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • Publication number: 20160346229
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: August 10, 2016
    Publication date: December 1, 2016
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • Patent number: 9446008
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: September 20, 2016
    Assignee: Gruenenthal GmbH
    Inventors: Ulrich Reinhold, Marc Schiller, Eva Wulsten, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts, Ulrich Feil
  • Publication number: 20160220516
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Application
    Filed: April 7, 2016
    Publication date: August 4, 2016
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • Publication number: 20160106688
    Abstract: An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Inventors: Thomas CHRISTOPH, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Petra BLOMS-FUNKE, Klaus SCHIENE, Ulrich FEIL
  • Publication number: 20130022670
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Application
    Filed: March 2, 2012
    Publication date: January 24, 2013
    Applicant: Gruenenthal GmbH
    Inventors: Ulrich REINHOLD, Marc Schiller, Eva Wulsten, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts
  • Publication number: 20120225951
    Abstract: An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Thomas CHRISTOPH, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts
  • Publication number: 20120225950
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS
  • Publication number: 20120220630
    Abstract: The present invention is concerned with an oral aqueous solution comprising prucalopride or pharmaceutically acceptable acid addition salts thereof having good organoleptic properties.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 30, 2012
    Inventor: Roger Carolus Augusta Embrechts
  • Publication number: 20080234291
    Abstract: The present invention concerns an oral solution comprising the MTP inhibitor mitratapide or an pharmaceutically acceptable acid addition salt thereof, a process for preparing such solutions, and their use in the treatment of MTP-related disorders such as hyperlipidemia, obesity, or type II diabetes.
    Type: Application
    Filed: January 18, 2005
    Publication date: September 25, 2008
    Inventors: Marc Karel Jozef Francois, Roger Carolus Augusta Embrechts, Willy Maria Albert Carlo Dries
  • Patent number: 6916479
    Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient, a synthetic, amphotheric phospholipid acting both as a second active ingredient and as a surface active agent, and art-known body or hair cleansing product ingredients as a carrier.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: July 12, 2005
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Roger Carolus Augusta Embrechts, Frank Christopher Odds, Piet Richard Gudula De Doncker
  • Patent number: 6514490
    Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient and 10′-undecen-3-oyl-aminopropyl trimethyl-ammonium methylsulfate as a second active ingredient.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: February 4, 2003
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Frank Christopher Odds, Roger Carolus Augusta Embrechts, Piet Richard Gudula De Doncker
  • Publication number: 20020058059
    Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient, a synthetic, amphotheric phospholipid acting both as a second active ingredient and as a surface active agent, and art-known body or hair cleansing product ingredients as a carrier.
    Type: Application
    Filed: October 13, 1999
    Publication date: May 16, 2002
    Inventors: ROGER CAROLUS AUGUSTA EMBRECHTS, FRANK CHRISTOPHER ODDS, PIET RICHARD GUDULA DE DONCKER
  • Publication number: 20010006981
    Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient and 10′-undecen-3-oyl-aminopropyl trimethyl-ammonium methylsulfate as a second active ingredient.
    Type: Application
    Filed: January 26, 2001
    Publication date: July 5, 2001
    Inventors: Frank Christopher Odds, Roger Carolus Augusta Embrechts, Piet Richard Gudula De Doncker
  • Patent number: 6207142
    Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient and 10′-undecen-3-oyl-aminopropyl trimethylammonium methylsulfate as a second active ingredient.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: March 27, 2001
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Frank Christopher Odds, Roger Carolus Augusta Embrechts, Piet Richard Gudula De Doncker
  • Patent number: 6077843
    Abstract: The present invention is concerned with a pharmaceutical composition suitable as a depot formulation for administration via intramuscular or subcutaneous injection, comprising:(1) as an active ingredient a therapeutically effective amount of a 9-hydroxyrisperidone fatty acid ester or a salt, or a stereoisomer or a stereoisomeric mixture thereof and(2) a pharmaceutically acceptable carrier;wherein the pharmaceutically acceptable carrier is water and the active ingredient is suspended therein; and with a process of preparing such a composition. The invention further concerns such a pharmaceutical composition for use as a medicament in the treatment of schizophrenia, non-schizophrenic psychoses, behavioural disturbances associated with neurodegenerative disorders, e.g. in dementia, behavioural disturbances in mental retardation and autism, bipolar mania, depression, anxiety.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: June 20, 2000
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Marc Karel Jozef Fran.cedilla.ois, Roger Carolus Augusta Embrechts, Herman Karel Borghijs, Johan Monbaliu
  • Patent number: 6054462
    Abstract: The present invention relates to a composition comprising an antimigraine compound of formula (I) and chitosan, which is particularly suited for intranasal administration. ##STR1## Process for preparing said composition, its use as a medicine and a nasal spray device, especially a unidose nasal spray device containing said composition.
    Type: Grant
    Filed: November 3, 1997
    Date of Patent: April 25, 2000
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Marc Karel Jozef Fran.cedilla.ois, Roger Carolus Augusta Embrechts, Lisbeth Illum